British scientists said the technique, which picks up circulating cancer cells in a patient’s blood, could be available on the NHS in as little as three years. Prostate cancer is the most common cancer among British men, with 47,000 diagnoses a year. Currently, men...
Queen Mary University of London (QMUL) and Queen Mary Innovations (QMI) are delighted to announce a first fundraise for Kinomica Ltd, an innovative R&D company specialising in cell-signal activity profiling for drug discovery and companion diagnostics development.
Professor Robert Hill, chair of dental physical sciences at Queen Mary University of London, has received the Varshneya Award for his pioneering research into halogen bioactive glasses for dental applications.
Commercialisation Executive, Eleftheria Ledaki is part of a panel at the UIIN conference in Helsinki.
Head of technology transfer BioPharma : Michele Hill- Perkins has co-authored a case study with 3rd Street, a Cedars-Sinai Technology Ventures established company: Non-invasive biomarker test for detection of pancreatic ductal adenocarcinoma (PDAC).
The pioneering work of a Queen Mary researcher has been celebrated with a stamp as part of a new series launched by Royal Mail.
For initial queries, please contact Lessia Djakowska, Office Manager or fill in the contact form
020 7882 5391